These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Elevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women. Tanaka KA; Bharadwaj S; Hasan S; Judd M; Abuelkasem E; Henderson RA; Chow JH; Williams B; Mazzeffi MA; Crimmins SD; Malinow AM Br J Anaesth; 2019 Jun; 122(6):751-759. PubMed ID: 30916034 [TBL] [Abstract][Full Text] [Related]
32. High-dose Factor XIII administration induces effective hemostasis for trauma-associated coagulopathy (TAC) both in vitro and in rat hemorrhagic shock in vivo models. Nagashima F; Inoue S; Koami H; Miike T; Sakamoto Y; Kai K J Trauma Acute Care Surg; 2018 Sep; 85(3):588-597. PubMed ID: 29851904 [TBL] [Abstract][Full Text] [Related]
33. Post-Transplantation Immunoadsorption Can Be Withheld in ABO-Incompatible Kidney Transplant Recipients. de Weerd AE; van Agteren M; Ijzermans JN; Weimar W; Betjes MG Ther Apher Dial; 2015 Oct; 19(5):513-7. PubMed ID: 26219347 [TBL] [Abstract][Full Text] [Related]
35. Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Green D; Ruth KJ; Folsom AR; Liu K Arterioscler Thromb; 1994 May; 14(5):686-93. PubMed ID: 8172846 [TBL] [Abstract][Full Text] [Related]
37. Non-autoimmune combined factor XIII A and B subunit deficiencies in rheumatoid arthritis patients treated with anti-interleukin-6 receptor monoclonal antibody (tocilizumab). Souri M; Mokuda S; Inanami H; Osaki T; Takasugi K; Ichinose A Thromb Res; 2016 Apr; 140():100-105. PubMed ID: 26938156 [TBL] [Abstract][Full Text] [Related]
38. The Effect of Ex Vivo Factor XIII Supplementation on Clot Formation in Blood Samples From Cardiac and Scoliosis Surgery Patients. Shams Hakimi C; Carling MS; Hansson EC; Brisby H; Hesse C; Radulovic V; Jeppsson A Clin Appl Thromb Hemost; 2018 May; 24(4):677-683. PubMed ID: 28651441 [TBL] [Abstract][Full Text] [Related]
39. Quality of Clotting Factor Activity in Fresh Frozen Plasma at Thaw with a Microwave System and after Storage at 4 degrees C for 48 Hours. Kuta P; Hauck-Dlimi B; Strobel J; Zimmermann R; Eckstein R Clin Lab; 2016; 62(6):987-91. PubMed ID: 27468559 [TBL] [Abstract][Full Text] [Related]
40. Terminal Phase Components of the Clotting Cascade in Patients with End-Stage Renal Disease Undergoing Hemodiafiltration or Hemodialysis Treatment. Pénzes K; Hurják B; Katona É; Becs G; Balla J; Muszbek L Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182600 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]